1090 studies found for:    "Retinoschisis" OR "Retinal Degeneration" OR "X-linked juvenile retinoschisis"
Show Display Options
Rank Status Study
21 Recruiting Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration
Conditions: Macular Degeneration;   Wet Macular Degeneration;   Retinal Degeneration;   Retinal Diseases;   Eye Diseases
Intervention: Drug: Aflibercept
22 Completed Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy
Conditions: Age-Related Maculopathy;   Age-Related Maculopathies;   Eye Diseases;   Retinal Degeneration;   Macular Degeneration
Interventions: Biological: RN6G;   Biological: Placebo
23 Completed Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration
Conditions: Age-Related Maculopathy;   Age-Related Maculopathies;   Eye Diseases;   Retinal Degeneration;   Macular Degeneration
Interventions: Biological: RN6G;   Biological: Placebo
24 Completed Measuring Reading Rehabilitation Outcomes
Conditions: Age Related Maculopathy;   Retinal Degeneration
Intervention: Procedure: Eccentric Viewing Training for Reading
25 Enrolling by invitation Safety & Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients
Conditions: Retinal Degeneration,;   Retinitis Pigmentosa
Intervention: Procedure: surgical implantation of subretinal device
26 Recruiting Argus® II Retinal Prosthesis System Post-Market Surveillance Study
Conditions: Outer Retinal Degeneration;   Retinitis Pigmentosa
Intervention:
27 Recruiting Retinal Imaging in Patients With Inherited Retinal Degenerations
Condition: Retinitis Pigmentosa
Intervention:
28 Recruiting High Resolution Retinal Imaging
Conditions: Stargardts;   Retinitis Pigmentosa;   Age-related Macular Degeneration;   Choroideremia;   Geographic Atrophy
Intervention: Procedure: Retinal imaging
29 Unknown  Long-Term Efficacy in AMD of Rheopheresis in North America
Condition: Macular Degeneration
Intervention: Device: Rheopheresis blood filtration
30 Recruiting Repository for Inherited Eye Diseases
Conditions: Retinitis Pigmentosa;   Inherited Ophthalmic Diseases
Intervention:
31 Recruiting A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies
Condition: Stargardt Disease
Intervention:
32 Completed Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration
Condition: Age Related Macular Degeneration
Interventions: Drug: ranibizumab, dexamethasone and verteporfin;   Drug: Ranibizumab
33 Unknown  Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System
Conditions: Macular Degeneration;   Choroidal Neovascularization
Intervention: Device: Ocular Brachytherapy
34 Terminated A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)
Conditions: Age Related Macular Degeneration;   Choroidal Neovascular Membrane;   Subfoveal Neovascular Age-Related Macular Degeneration;   Macular Degeneration;   Wet Age-Related Macular Degeneration
Intervention: Drug: Ranibizumab
35 Recruiting Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)
Conditions: Stargardt's Macular Dystrophy;   Fundus Flavimaculatus;   Juvenile Macular Dystrophy
Intervention: Biological: MA09-hRPE
36 Active, not recruiting Argus® II Retinal Stimulation System Feasibility Protocol
Condition: Retinitis Pigmentosa
Intervention: Device: Argus II Retinal Stimulation System
37 Completed
Has Results
Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A
Condition: Retinitis Pigmentosa
Interventions: Drug: Lutein;   Dietary Supplement: Cornstarch control
38 Completed Pain Perception at Laser Treatment
Condition: Laser Therapy, Low-Level
Intervention: Procedure: retina photocoagulation
39 Completed Ranibizumab "Treat and Extend" in Diabetic Macular Edma
Condition: Diabetic Macular Edema
Intervention: Drug: Ranibizumab
40 Completed Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract Surgery
Condition: Macular Edema
Interventions: Drug: Nepafenac 0.1%;   Drug: Ketorolac 0.5%;   Other: Placebo (sterile saline drops)

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years